Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Children

A Clinical Trial of an Quadrivalent Inactivated Influenza Vaccine in Healthy Children Aged 6 to 35 Months

NCT05212623 ·Status: COMPLETED ·Phase: PHASE1

Immunogenicity and Safety of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine in Infants

NCT01494740 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults

NCT01776541 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years

NCT05313893 ·Status: COMPLETED ·Phase: PHASE4

A Clinical Trial of an Quadrivalent Influenza Virus Subunit Vaccine in Chinese Children Aged 6 to 35 Months

NCT05645900 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of Booster Dose of An Inactivated,Adjuvanted Whole-Virion Pandemic Influenza(H5N1)Vaccine

NCT00660257 ·Status: COMPLETED ·Phase: PHASE1

The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated) （Children Forms of Drug）

NCT01551823 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenocity Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Japanese Children

NCT01001169 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years

NCT05144464 ·Status: UNKNOWN ·Phase: PHASE4

Safety and Immunogenicity Study of Two Doses of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)

NCT00517517 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults

NCT00449670 ·Status: COMPLETED ·Phase: PHASE3

Immunogenicity Study of S-OIV H1N1 Influenza Vaccine

NCT01096225 ·Status: UNKNOWN

Safety and Immunogenicity Study of a H5N1 Influenza Vaccine (Vero Cell-Derived, Whole Virus) in Healthy Infants, Children and Adolescents

NCT01052402 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated)

NCT01551810 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in Children

NCT00491985 ·Status: COMPLETED ·Phase: PHASE2

Lot-to-lot Consistency of Quadrivalent Influenza Vaccine (Split Virion), Inactivated

NCT05512494 ·Status: COMPLETED ·Phase: PHASE4

Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (7.5μg/0.25ml)

NCT03859141 ·Status: COMPLETED ·Phase: PHASE3

Clinical Trial of Quadrivalent Influenza Virus Split Vaccine in Population Aged 3-8 Years

NCT05138705 ·Status: COMPLETED ·Phase: PHASE4

To Identify the Immunogenicity and Safety of QIV in Children Aged 3-8 Years

NCT05389137 ·Status: UNKNOWN ·Phase: PHASE4

A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age.

NCT02914275 ·Status: COMPLETED ·Phase: PHASE3

A/H5N1 Vaccine in Healthy Children Aged 2-9 Years

NCT00133536 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months

NCT06049927 ·Status: COMPLETED ·Phase: PHASE3

A Study of Influenza Virus Vaccines in Children and Adults

NCT00988143 ·Status: COMPLETED ·Phase: PHASE2

Influenza A/H5N1 Vaccine Clinical Trial (IVACFLU-A/H5N1) - Phase 1

NCT02171819 ·Status: COMPLETED ·Phase: PHASE1

Immunogenicity and Safety Study of Inactivated Subunit H5N1 Influenza Vaccine in Prior Recipients of Live Attenuated H2N2, H6N1 and H9N2 Influenza Vaccines and in H5N1 and Live Attenuated Vaccine Naïve Individuals

NCT03816878 ·Status: COMPLETED ·Phase: PHASE1